Monitoring of high-risk antipsychotic drugs unchanged despite FDA warnings

A new study concludes that many doctors appear to have largely ignored a U.S. Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general.

Read the whole article on Science Daily

More from Science Daily